Sportizumab – Multimodal progressive exercise over 10 weeks decreases T frequency and Cd expression on C+ T cells in relapsing-remitting multiple sclerosis: A randomized controlled trial
S. Proschinger, S. Belen, F. Adammek, M.L. Schlagheck, A. Rademacher, A. Schenk, C. Warnke, W. Bloch, P. Zimmer, Brain, Behavior, and Immunity 124 (2024) 397–408.